Ping An Healthcare Technology, Beijing.
National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
AMIA Annu Symp Proc. 2021 Jan 25;2020:737-746. eCollection 2020.
IgA nephropathy (IgAN) is common worldwide and has heterogeneous phenotypes. Predicting long-term outcomes is important for clinical decision-making. As right-censored patients become common during the long-term follow-up, either excluding these patients from the cohort or labeling them as control will bias the risk estimation. Thus, we constructed a survival model using EXtreme Gradient Boosting for survival (XSBoost-Surv), to accurately predict the prognosis of IgAN patients by taking the time-to-event information into the modeling procedure. Shapley Additive exPlanations (SHAP) was employed to interpret the individual predicted result and the non-linear relationships between the predictors and outcome. Experiments on real-world data showed our model achieved superior discrimination performance over other conventional survival methods. By providing insights into the exact changes in risk induced by certain characteristics of the patients, this explainable and accurate survival model can help improve the clinical understanding of renal progression and benefit the therapies for the IgAN patients.
IgA 肾病(IgAN)在全球范围内较为常见,具有异质性表型。预测长期结局对于临床决策非常重要。由于在长期随访过程中,右删失患者变得较为常见,如果将这些患者从队列中排除或将其标记为对照,将导致风险估计出现偏差。因此,我们构建了一个使用极端梯度提升进行生存分析(XSBoost-Surv)的生存模型,通过将事件时间信息纳入建模过程,准确预测 IgAN 患者的预后。我们还使用 Shapley Additive exPlanations(SHAP)来解释个体预测结果以及预测因子与结局之间的非线性关系。在真实世界数据上的实验表明,我们的模型在判别性能上优于其他传统的生存方法。通过深入了解患者某些特征所引起的风险确切变化,这个可解释且准确的生存模型有助于提高对肾脏进展的临床认识,并为 IgAN 患者的治疗带来益处。